NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,164,000 | +266.0% | 49,600 | +142.0% | 0.04% | -61.9% |
Q4 2014 | $318,000 | -54.9% | 20,500 | -64.9% | 0.10% | -78.3% |
Q3 2014 | $705,000 | +235.7% | 58,400 | +256.1% | 0.48% | +393.9% |
Q2 2014 | $210,000 | -64.9% | 16,400 | -66.8% | 0.10% | -44.0% |
Q1 2014 | $599,000 | – | 49,400 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |